Cardiopulmonary bypass has revolutionized the practice of cardiac surgery and allows safe conduct of increasingly complex cardiac surgery. A brief review of the bypass circuit is undertaken in this review. A more thorough review of the anesthetic management is accomplished including choice of anesthetic medications and their effects. The inflammatory response to cardiopulmonary bypass is reviewed along with interventions that may help ameliorate the inflammation.
VretzakisGFerdiEArgiriadouH. Influence of bispectral index monitoring on decision making during cardiac anesthesia. J Clin Anesth. 2005;17:509-516.
2.
SerfonteinL. Awareness in cardiac anesthesia. Curr Opin Anaesthesiol. 2010;23:103-108.
3.
MathewJPWeatherwaxKJEastCJWhiteWDRevesJG. Bispectral analysis during cardiopulmonary bypass: the effect of hypothermia on the hypnotic state. J Clin Anesth. 2001;13:301-305.
4.
PuriGDMurthySS. Bispectral index monitoring in patients undergoing cardiac surgery under cardiopulmonary bypass. Eur J Anaesthesiol. 2003;20:451-456.
5.
BauerMWilhelmWKraemerT. Impact of bispectral index monitoring on stress response and propofol consumption in patients undergoing coronary artery bypass surgery. Anesthesiology. 2004;101:1096-1104.
6.
WhitlockELTorresBALinN. Postoperative delirium in a substudy of cardiothoracic surgical patients in the BAG-RECALL clinical trial [published online January 9, 2014]. Anesth Analg. doi:10.1213/ANE.0000000000000028
7.
MurkinJMAdamsSJQuantzMBainbridgeDNovickRJ. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 20007;104:51-58.
8.
MurkinJMArangoM. Near infrared spectroscopy as an index of brain and tissue oxygenation. Br J Anaesth. 2009;103(suppl 1):i3-i13.
9.
HarilallYAdamJKBiccardBMReddiA. The effect of optimizing cerebral tissue oxygen saturation on markers of neurological injury during coronary artery bypass graft surgery. Heart Lung Circ. 2014;23:68-74.
10.
BrassardPPelletierCMartinM. Influence of norepinephrine and phenylephrine on frontal lobe oxygenation during cardiopulmonary bypass in patients with diabetes [published online December 17, 2013]. J Cardiothorac Vasc Anesth. doi:10.1053/j.jvca.2013.09.006.
11.
ZhuFLeeACheeYE. Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev. 2012;(10):CD003587. doi:10.1002/14651858.CD003587.pub2.
12.
GrecoMLandoniGBiondi-ZoccaiG. Remifentanil in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2012;26:110-116.
13.
WongGTHuangZJiSIrwinMG. Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. J Cardiothorac Vasc Anesth. 2010;24:790-796.
14.
MylesPSHuntJOFletcherH. Remifentanil, fentanyl, and cardiac surgery: a double-blinded, randomized, controlled trial of costs and outcomes. Anesth Analg. 2002;95:805-812.
15.
Von DossowVLuetzAHaasA. Effects of remifentanil and fentanyl on the cell-mediated immune response in patients undergoing elective coronary artery bypass graft surgery. J Int Med Res. 2008;36:1235-1247.
16.
StephanHSonntagHSchenkHDKettlerDKhambattaHJ. Effects of propofol on cardiovascular dynamics, myocardial blood flow and myocardial metabolism in patients with coronary artery disease. Br J Anaesth. 1986;58:969-975.
17.
MaGChenJMengXDengLGaoYMengJ. High-dose propofol reduces S-100β protein and neuron-specific enolase levels in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2013;27:510-515.
18.
VasileiouIXanthosTKoudounaE. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol. 2009;605:1-8.
19.
CuthbertsonBHSprungCLAnnaneD. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med. 2009;35:1868-1876.
20.
FreundFYJabrePMouradJ. Relative adrenal insufficiency in critically ill patients after rapid sequence intubation: KETASED ancillary study [published online January 3, 2014]. J Crit Care. doi:10.1016/j.jcrc.2013.12.018.
21.
MorelJSalardMCastelainC. Haemodynamic consequences of etomidate administration in elective cardiac surgery: a randomized double-blinded study. Br J Anaesth. 2011;107:503-509.
22.
WeltersIDFeurerMKPreissV. Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth. 2011;106:172-179.
23.
DaleOSomogyiAALiYSullivanTShavitY. Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis. Anesth Analg. 2012;115:934-943.
24.
OzarslanNGAyhanBKanbakM. Comparison of the effects of sevoflurane, isoflurane, and desflurane on microcirculation in coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2012;26:791-798.
25.
FradorfJHuhnRWeberNC. Sevoflurane-induced preconditioning: impact of protocol and aprotonin administration on infarct size and endothelial nitric-oxide synthase phosphorylation in the rat heart in vivo. Anesthesiology. 2010;113:1289-1298.
26.
LiuKXXiaZ. Potential synergy of antioxidant N-acetylcysteine and insulin in restoring sevoflurane postconditioning cardioprotection in diabetes. Anesthesiology. 2012;116:488-489.
27.
GamperlAKHeinTWKuoLCasonBA. Isoflurane-induced dilation of porcine coronary microvessel is endothelium dependent and inhibited by glibendamide. Anesthesiology. 2002;96:1465-1471.
SepacASedlicFSi-TayebK. Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells. Anesthesiology. 2010;113:906-916.
30.
JulierKda SilvaRGarciaC. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology. 2003;98:1315-1327.
31.
LandoniGGrecoTBiondi-ZoccaiG. Anaesthetic drugs and survival: a Bayesian network meta-analysis of randomized trials in cardiac surgery. Br J Anaesth. 2013;111:886-896.
32.
WatanabeGTomitaSYamaguchiSYashikiN. Awake coronary artery bypass grafting under thoracic epidural anesthesia: great impact on off-pump coronary revascularization and fast-track recovery. Eur J Cardiothorac Surg. 2011;40:788-793. doi:10.1016/j.ejcts.2011.01.034.
33.
LiuSSBlockBMWuCL. Effects of perioperative central neuraxial analgesia on outcome after coronary artery bypass surgery. Anesthesiology. 2004;101:153-161.
34.
BignamiELandoniGBiondi-ZoccaiGG. Epidural analgesia improves outcome in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2010;24:586-597.
35.
LeeTWRGrocottHPSchwinnDJacobsohnE. High spinal anesthesia for cardiac surgery. Anesthesiology. 2003;98:499-510.
36.
SvircevicVvan DijkDNierichAP. Meta-analysis of thoracic epidural anesthesia versus general anesthesia for cardiac surgery. Anesthesiology. 2011;114:271-282.
37.
HemmerlingTMCyrSTerrasiniN. Epidural catheterization in cardiac surgery: the 2012 risk assessment. Ann Card Anaesth. 2013;16:169-177.
38.
WeinerMMRosenblattAMittnachtAJC. Neuraxial anesthesia and timing of heparin administration in patients undergoing surgery for congenital heart disease using cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2012;26:581-584.
39.
FongLSBassinLMathurMN. Liberal use of axillary artery cannulation for aortic and complex cardiac surgery. Interact Cardiovasc Thorac Surg. 2013;16:755-758.
40.
WangYGaoCQWangGWangJL. Transesophageal echocardiography guided cannulation for peripheral cardiopulmonary bypass during robotic cardiac surgery. Chin Med J (Engl). 2012;125:3236-3239.
41.
LobatoRLDespotisGJLevyJHShore-LessersonLJCarlsonMOBennett-GuerreroE. Anticoagulation management during cardiopulmonary bypass: a survey of 54 North American institutions. J Thorac Cardiovasc Surg. 2010;139:1665-1666.
42.
GarvinSFitzgeraldDCDespotisGShekarPBodySC. Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements. Anesth Analg. 2010;111:849055.
43.
FitzgeraldDJPatelABodySCGarvinS. The relationship between heparin level and activated clotting time in the adult cardiac surgery population. Perfusion. 2009;24:93-96.
44.
GarvinSFitzgeraldDMuehlschlegelJD. Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations. Anesth Analg. 2010;111:856-861.
45.
RoyseAGRoyseCF. Epiaortic ultrasound assessment of the aorta in cardiac surgery. Best Pract Res Clin Anaesthesiol. 2009;23:335-341.
46.
GlasKESwaminathanMReevesST. Guidelines for the performance of a comprehensive intraoperative epiaortic ultrasonographic examination: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists; Endorsed by the Society of Thoracic Surgeons. Anesth Analg. 2008;106:1376-1384.
47.
MurphyGSHesselEAIIGroomRC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg. 2009;108:1394-1417.
48.
MurkinJMFarrarJKTweedWAMcKenzieFNGuiraudonG. Cerebral autoregulation and flow/metabolism coupling during cardiopulmonary bypass: the influence of PaCO2. Anesth Analg. 1987;66:825-832.
49.
LarsenFSOlsenKSHansenBAPaulsonOBKnudsenGM. Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke. 1994;25:1985-1988.
50.
CookDJProperJAOrszulakTADalyRCOliverWC. Effect of pump flow rate on cerebral blood flow during hypothermic cardiopulmonary bypass in adults. J Cardiothorac Vasc Anesth. 1997;11:415-419.
51.
FoxLSBlackstoneEHKirklinJW. Relationship of whole body oxygen consumption to perfusion flow rate during hypothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1982;83:239-248.
52.
NiinikoskiJLaaksonenVMeretojaOJalonenJInbergMV. Oxygen transport to tissue under normovolemic moderateand extreme hemodilution during coronary bypass operation. Ann Thorac Surg. 1981;31:134-143.
53.
OsawaHYoshiiSAbrahamSJK. Critical values of hematocrit and mixed venous oxygen saturation as parameters for a safe cardiopulmonary bypass. Jpn J Thorac Cardiovasc Surg. 2004;52:49-56.
54.
RanucciMRomittiFIsgroG. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg. 2005;80:2213-2220.
55.
GrigoreAMGrocottHPMathewJP; Neurologic Outcome Research Group of the Duke Heart Center. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg. 2002;94:4-10.
56.
GrigoreAMMurrayCFRamakrishnaHDjaianiG. A core review of temperature regimens and neuroprotection during cardiopulmonary bypass: does rewarming rate matter?Anesth Analg. 2009;109:1741-1751.
57.
MohrRLaveeJGoorDA. Inaccuracy of radial artery pressure measurement after cardiac operations. J Thorac Cardiovasc Surg. 1987;94:286-290.
58.
GrocottHPStafford-SmithMMora ManganoCT. Cardiopulmonary Bypass Management and Organ Protection in Kaplan’s Cardiac Anesthesia. Philadelphia, PA: Saunders; 2011:838-887.
59.
SchwarzBBowdleTAJettGK. Biphasic shocks compared with monophasic damped sine wave shocks for direct ventricular defibrillation during open heart surgery. Anesthesiology. 2003;98:1063-1069.
60.
LuJGPensieroAAponte-PatelL. Short-term reduction in intrinsic heart rate during biventricular pacing after cardiac surgery: a substudy of a randomized clinical trial. J Thorac Cardiovasc Surg. 2013;146:1494-1500.
61.
Al-RashidiFLandenhedMBlomquistS. Comparison of the effectiveness and safety of a new de-airing technique with a standardized carbon dioxide insufflation technique in open left heart surgery: a randomized clinical trial. J Thorac Cardiovasc Surg. 2011;141:1128-1133.
ApostolakisEEKoletsisENBaikroussisNGSiminelakisSNPapdopoulosGS. Strategies to prevent intraoperative lung injury during cardiopulmonary bypass. J Cardiothorac Surg. 2010;5:1-9.
64.
NgCSHArifiAAWanS. Ventilation during cardiopulmonary bypass: impact on cytokine response and cardiopulmonary function. Ann Thorac Surg. 2008;85:154-162.
65.
ImuraHCaputoMLimK. Pulmonary injury after cardiopulmonary bypass: beneficial effects of low-frequency mechanical ventilation. J Thorac Cardiovasc Surg. 2009;137:1530-1537.
66.
JohnLErvineI. A study assessing the potential benefit of continued ventilation during cardiopulmonary bypass. Interact Cardiovasc Thorac Surg. 2008;7:14-17.
67.
TutunUParlarAIAltinayL. Does on-pump normothermic beating-heart valve surgery with low tidal volume ventilation protect the lungs?Heart Surg Forum. 2011;14:E297-E301.
68.
SchreiberJULanceMDde KorteMArtmannTAleksicIKrankeP. The effect of different lung-protective strategies in patients during cardiopulmonary bypass: a meta-analysis and semiquantitative review of randomized trials. J Cardiothorac Vasc Anesth. 2012;26:448-454.
69.
CogliatiAAMenichettiATritapepeLContiG. Effects of three techniques of lung management on pulmonary function during cardiopulmonary bypass. Acta Anaesthesiol Belg. 1996;47:73-80.
70.
MurphyGSSzokolJWCurranRDVotapkaTVVenderJS. Influence of a vital capacity maneuver on pulmonary gas exchange after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2001;15:336-340.
71.
DiNardoJA. Pro: Calcium is routinely indicated during separation from cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:905-907.
72.
PrielippRButterworthJ. Con: Calcium is not routinely indicated during separation from cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:908-912.
73.
RoysterRLButterworthJF4thPrielippRC. A randomized, blinded, placebo-controlled evaluation of calcium chloride and epinephrine for inotropic support after emergence from cardiopulmonary bypass. Anesth Analg. 1992;74:3-13.
74.
ZangrilloABiondi-ZoccaiGMizziA. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth. 2009;23:474-478.
75.
LandoniGMizziABiondi-ZoccaiG. Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2010;24:51-57.
76.
DelaneyABradfordCMcCaffreyJBagshawSMLeeR. Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomized controlled trials. Int J Cardiol. 2010;138:281-289.
77.
LomivorotovVBoboshkoVAEfremovSM. Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients. J Cardiothorac Vasc Anesth. 2012;26:596-603.
78.
VegasA. Assisting the failing heart. Anesthesiol Clin. 2008;26:539-564.
79.
WeinerMMLinHMDanforthDRaoSHosseinianLFischerGW. Methylene blue is associated with poor outcomes in vasoplegic shock. J Cardiothorac Vasc Anesth. 2013;27:1233-1238.
80.
UdehCIDiaz-GómezJLAnthonyDSatyapriyaAPerez-ProttoSHataJS. Recent advances in perioperative anesthetic management update on the role of vasopressin and its effects on outcomes. Curr Pharm Des. 2012;18:6308-6313.
81.
BaskettRJGhaliWAMaitlandAHirschGM. The intraaortic balloon pump in cardiac surgery. Ann Thorac Surg. 2002;74:1276-1287.
82.
SáMPFerrazPEEscobarRR. Prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass surgery: a meta-analysis of randomized controlled trials. Coron Artery Dis. 2012;23:480-486.
83.
LombardFWGrichnikKP. Update on management strategies for separation from cardiopulmonary bypass. Curr Opin Anaesthesiol. 2011;24:49-57.
84.
RisnesIWagnerKUelandTMollnesTAukrustPSvennevigJ. Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment. Perfusion. 2008;23:173-178.
85.
EltzschigHKRosenbergerPLofflerMFoxJAArankiSFShernanSK. Impact of intraoperative transesophageal echocardiography on surgical decisions in 12,566 patients undergoing cardiac surgery. Ann Thorac Surg. 2008;85:845-852.
86.
DenaultAYDeschampsACoutureP. Intraoperative hemodynamic instability during and after separation from cardiopulmonary bypass. Semin Cardiothorac Vasc Anesth. 2010;14:165-182.
87.
DeLariaGATynerJJHayesCLArmstrongBW. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery. Arch Surg. 1994;129:944-950.
88.
RungeMMøllerCHSteinbrüchelDA. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study. J Extra Corpor Technol. 2009;41:10-14.
89.
AugoustidesJGT. The inflammatory response to cardiac surgery with cardiopulmonary bypass: should steroid prophylaxis be routine?J Cardiothorac Vasc Anesth. 2012;26:952-958.
90.
WarrenOJSmithAJAlexiouC. The inflammatory response to cardiopulmonary bypass: part I—mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009;23:223-231.
91.
SvyatetsMTolaniKZhangMTulmanGCharchafliehJ. Perioperative management of deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth. 2010;24:644-655.
92.
LevyJHTanakaKA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003;75:S715-S720.
93.
WarrenOJSmithAJAlexiouC. The inflammatory response to cardiopulmonary bypass: part I—mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009;23:223-231.
94.
MurphyGSWhitlockRPGutscheJTAugoustidesJG. Steroids for adult cardiac surgery with cardiopulmonary bypass: update on dose and key randomized trials. J Cardiothorac Vasc Anesth. 2013;27:1053-1059.
95.
DielemanJMNierichAPRosseelPM; Dexamethasone for Cardiac Surgery (DECS) Study Group. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012;308:1761-1767.
96.
VivianoAKanagasabayRZakkarM. Is perioperative corticosteroid administration associated with a reduced incidence of postoperative atrial fibrillation in adult cardiac surgery?Interact Cardiovasc Thorac Surg. 2014;18:225-229.
LomivorotovVVEfremovSMKalinichenkoAP. Methylprednisolone use is associated with endothelial cell activation following cardiac surgery. Heart Lung Circ. 2013;22:25-30.
99.
TaggartDPel-FikyMCarterRBowmanAWheatleyDJ. Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg. 1993;56:1123-1128.
100.
MackMJBrownPPKugelmassAD. Current status and outcomes of coronary revascularization 1999-2002: 148,396 surgical and percutaneous procedures. Ann Thorac Surg. 2004;77:761-766.
101.
MessentMSullivanKKeoghBFMorganCJEvansTW. Adult respiratory disease syndrome following cardiopulmonary bypass: incidence and prediction. Anaesthesia. 1992;47:267-268.
102.
ClarkSC. Lung injury after cardiopulmonary bypass. Perfusion. 2006;21:225-228.
103.
RadyMYRyanTStarrNJ. Early onset of acute pulmonary dysfunction after cardiovascular surgery: risk factors and clinical outcome. Crit Care Med. 1997;25:1831-1839.
104.
TschernkoEMBambazekAWisserW. Intrapulmonary shunt after cardiopulmonary bypass: the use of vital capacity maneuvers versus offpump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2002;124:732-738.
105.
PuskasJDWilliamsWHDukePG. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:797-808.
106.
de VroegeRvan OeverenWvan KlarenboschJ. The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators. Anesth Analg. 2004;98:1586-1594.
107.
WeerwindPWMaessenJGvan TitsLJ. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass. J Thorac Cardiovasc Surg. 1995;110:1633-1641.
108.
BozdayiMBorowiecJNilssonLVengePThelinSHanssonHE. Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery. Artif Organs. 1996;20:1008-1016.
109.
FukutomiMKobayashiSNiwayaKHamadaYKitamuraS. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment. Artif Organs. 1996;20:767-776.
110.
WanSLeClercJLAntoineMDeSmetJMYimAPVincentJL. Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study. Ann Thorac Surg. 1999;68:1230-1235.
111.
te VelthuisHBaufretonCJansenPG. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations. J Thorac Cardiovasc Surg. 1997;114:117-122.
112.
OvrumETangenGTollofsrudS. Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2011;141:1145-1149.
113.
SpeekenbrinkRvan OeverenWWildevuurC. Pathophysiology of Cardiopulmonary Bypass, Minimally Invasive Cardiac Surgery. Totowa, NJ: Humana Press; 2004:3-18.
114.
SakwaMPEmeryRWShannonFL. Coronary artery bypass grafting with minimized cardiopulmonary bypass circuit: a prospective randomized trial. J Thorac Cardiovasc Surg. 2009;137:481-485.
115.
BenedettoUAngeloniEReficeS. Is minimized extracorporeal circulation effective to reduce the need for red blood cell tranfusion in coronary artery bypass grafting? Meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg. 2009;138:1450-1453.
SheppardSGippsRSmithD. Does leukocyte depletion during cardiopulmonary bypass improve oxygenation indices in patients with mild lung dysfunction?Br J Anaesth. 2004;93:789-792.
118.
WarrenOAlexiouCMasseyR. The effects of various leukocyte filtration strategies in cardiac surgery. Eur J Cardiothorac Surg. 2007;31:665-676.
119.
WarrenOWallaceSMasseyR. Does systemic leukocyte filtration affect perioperative hemorrhage in cardiac surgery? A systematic review and meta-analysis. ASAIO J. 2007;53:514-521.
120.
FerrarisVABrownJRDespotisGJ. 2011 Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944-982.
121.
DeFoeGRRossCSOlmsteadEM. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg. 2001;71:769-776.
122.
HwangJHuhJKimJ. The effect of retrograde autologous priming of the cardiopulmonary bypass circuit on cerebral oxygenation. J Cardiothorac Vasc Anesth. 2011;25:995-999.
123.
PearlJMManningPBMcNamaraJLSaucierMMThomasDW. Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass. Ann Thorac Surg. 1999;68:1369-1375.
124.
MahmoudABBurhaniMSHannefAAJamjoomAAAl GithmiISBaslaimGM. Effect of modified ultrafiltration on pulmonary function after cardiopulmonary bypass. Chest. 2005;128:3447-3453.
125.
NagashimaMShin’okaTNollertGShum-TimDRaderCMMayerJEJr.High-volume continuous hemofiltration during cardiopulmonary bypass attenuates pulmonary dysfunction in neonatal lambs after deep hypothermic circulatory arrest. Circulation. 1998;98:II378-II384.
126.
TallmanRDDumondMBrownD. Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass. Perfusion. 2002;17:111-115.
127.
WeberCFJamborCStrasserC. Normovolemic modified ultrafiltration is associated with better preserved platelet function and less postoperative blood loss in patients undergoing complex cardiac surgery: a randomized and controlled study. J Thorac Cardiovasc Surg. 2011;141:1298-1304.
128.
TorinaAGSilveira-FilhoLMVilarinhoKAS. Use of modified ultrafiltration in adults undergoing coronary artery bypass grafting is associated with inflammatory modulation and less postoperative blood loss: a randomized and controlled study. J Thorac Cardiovasc Surg. 2012;144:663-670.
129.
PapdopoulosNBakhtiaryFGrunVWeberCFStrasserCMoritzA. The effect of normovolemic modified ultrafiltration on inflammatory mediators, endotoxins, terminal complement complexes and clinical outcome in high-risk cardiac surgery patients. Perfusion. 2013;28:306-314.
130.
LomivorotovVVForminskiyEVEfremovSM. Hypertonic solution decreases extravascular lung water in cardiac patients undergoing cardiopulmonary bypass surgery. J Cardiothorac Vasc Anesth. 2013;27:273-282.
131.
WesterbergMBengtssonAJeppssonA. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg. 2004;78:54-59.
132.
AldeaGSSoltowLOChandlerWL. Limitation of thrombin generation, platelet activation, inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg. 2002;123:742-755.
133.
BoonstraPWvan ImhoffGWEysmanL. Reduced platelet activation and improved hemostasis after controlled cardiotomy suction during clinical membrane oxygenator perfusions. J Thorac Cardiovasc Surg. 1985;89:900-906.
134.
TatarHCicekSDemirkilicU. Topical use of aprotinin in open heart operations. Ann Thorac Surg. 1993;55:659-661.
135.
NakahiraASasakiYHiraiH. Cardiotomy suction, but not open venous reservoirs, activates coagulofibrinolysis in coronary artery surgery. J Thorac Cardiovasc Surg. 2011;141:1289-1297.
